Previous 10 | Next 10 |
Babylon Holdings Limited (NYSE:BBLN) (“Babylon”) notes the movement in its share price on April 22, 2022, with over 45x the average daily trading volume seen since its NYSE listing on October 22, 2021, concurrent with the expiry of Babylon’s 6-month lock-up of appro...
Citi Investment Research has grouped telehealth provider, Teladoc Health (NYSE:TDOC) and membership-based primary care platform 1Life Healthcare (ONEM) among health tech stocks highly exposed to the risk of a recession. This month, the economists polled by The Wall Street Journal...
Gainers: Vallon Pharmaceuticals (VLON) +80%. Blueknight Energy Partners (BKEP) +38%. Moving iMage Technologies (MITQ) +37%. RISE Education Cayman (REDU) +15%. Sky Harbour Group (SKYH) +14%. GWG Holdings (GWGH) +14%. Evelo Biosciences (EVLO) +13%. Chindata Group Holdings (CD) +13%. Shattuck La...
Gainers: Vallon Pharmaceuticals (VLON) +84%. Shattuck Labs (STTK) +12%. Establishment Labs (ESTA) +11%. INVO Bioscience (INVO) +5%. Novan (NOVN) +5%. Losers: Babylon Holdings (BBLN) -41%. SCYNEXIS (SCYX) -25%. Clarus Therapeutics (CRXT) -16%. HCA H...
Babylon (NYSE: BBLN) (“Babylon” or the “Company”) will host a conference call on Thursday, May 12, 2022, at 8:00 AM Eastern Time to review the Company’s first quarter 2022 financial results. A press release announcing the first quarter results will...
Babylon Holdings Limited (NYSE:BBLN) (“Babylon” or “the Company”), one of the world’s fastest growing digital healthcare companies, today announced that its Annual Report on Form 20-F for the fiscal year ended December 31, 2021 has been filed with the ...
Babylon (NYSE: BBLN) today announced the integration of its AI-powered Symptom Checker technology into Higi ’s mobile application, opening a new channel for proactive self-care health engagement for Higi’s thousands of U.S. app users. The integration follows Baby...
Gainers: Clearside Biomedical CLSD +38%. Cellectis (NASDAQ:CLLS) +13%. NeuroPace (NASDAQ:NPCE) +12%. 4D pharma LBPS +11%. LifeStance Health (NASDAQ:LFST) +8%. Losers: Orphazyme ORPH -37%. Aesthetic Medical International (NASDAQ:AIH) -19%. Suns...
Babylon Holdings Ltd (BBLN) Q4 2021 Earnings Conference Call March 10, 2022 8:00 AM ET Company Participants Ali Parsadoust – Founder and Chief Executive Officer Charlie Steel – Chief Financial Officer Conference Call Participants David Larsen – BTIG Glen Santangelo ȁ...
Babylon Holdings press release (NYSE:BBLN): Q4 GAAP EPS of -$0.65. Revenue of $119.69M (+192.2% Y/Y). Guidance for 2022 revenue to grow again almost another three times to $900 million to $1 billion, a 3x increase over 2021 revenue, with the incremental increase from December 2021 run rate. T...
News, Short Squeeze, Breakout and More Instantly...
Babylon Holdings Limited Class A Company Name:
BBLN Stock Symbol:
NYSE Market:
Babylon (NYSE: BBLN) (the “Company”) today announced it will host a conference call to review its first quarter financial results on Wednesday, May 10, 2023, at 8:00 AM Eastern Time. A press release announcing the results will be issued prior to the conference call on Wednesday, May...
Chronic conditions include diabetes, hypertension, anxiety, depression, low back pain, and prenatal care Babylon’s technology will collect and analyze data to monitor patients in real-time Personalized care teams will tailor evidence-based programs for each member C...
Revenue grew 3.5x YoY, to $1.11 billion, exceeding guidance Cost of Care Delivery (COCD) Margin in the U.K. already profitable 1 , with U.S. Clinical services also expecting COCD profitability in early 2023 Key U.S. VBC contracts delivered profitable Medical Margins 2 in t...